Showing results (111-120 of 529) with videos related to
Sort By:
Pageof 53
Cells|February 13, 2020
Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver DiseasesViviana Cernigliaro, Rossella Peluso, Beatrice Zedda, et al.Journal of Digestive Diseases|May 18, 2019
Precision medicine in primary biliary cholangitisVincenzo Ronca, Alessio Gerussi, Laura Cristoferi, et al.Autoimmunity|January 8, 2008
Serum autoantibodies: a road map for the clinical hepatologistFrancesca Meda, Massimo Zuin, Pietro Invernizzi, et al.Autoimmunity|April 25, 2008
Skewing of X chromosome inactivation in autoimmunityPietro Invernizzi, Simone Pasini, Carlo Selmi, et al.Journal of Autoimmunity|July 23, 2013
The limitations and hidden gems of the epidemiology of primary biliary cirrhosisMauro Podda, Carlo Selmi, Ana Lleo, et al.Mediators of Inflammation|July 7, 2015
Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver DiseasesHaiyan Zhang, Francesca Bernuzzi, Ana Lleo, et al.Cancer Detection and Prevention|December 4, 2003
Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinomaNicola Leone, Rinaldo Pellicano, Franco Brunello, et al.Panminerva Medica|November 9, 2020
Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: systematic review and meta-analysisAbdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, et al.Journal of Translational Autoimmunity|January 10, 2022
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?Giacomo Mulinacci, Andrea Palermo, Laura Cristoferi, et al.Endocrine|October 30, 2021
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational studySara Massironi, Federica Cavalcoli, Alessandra Elvevi, et al.Pageof 53